olopatadine hydrochloride ophthalmic solution

Generic: olopatadine hydrochloride ophthalmic solution

Labeler: target corporation
NDC Directory HUMAN OTC DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name olopatadine hydrochloride ophthalmic solution
Generic Name olopatadine hydrochloride ophthalmic solution
Labeler target corporation
Dosage Form SOLUTION/ DROPS
Routes
OPHTHALMIC
Active Ingredients

olopatadine hydrochloride 1 mg/mL

Manufacturer
Target Corporation

Identifiers & Regulatory

Product NDC 11673-689
Product ID 11673-689_9c7c23fe-8fd3-d3b0-1410-83df55fa5db2
Product Type HUMAN OTC DRUG
Marketing Category ANDA
Application Number ANDA209619
Listing Expiration 2026-12-31
Marketing Start 2021-10-22

Pharmacologic Class

Classes
decreased histamine release [pe] histamine h1 receptor antagonists [moa] histamine-1 receptor antagonist [epc] histamine-1 receptor inhibitor [epc] mast cell stabilizer [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 11673689
Hyphenated Format 11673-689

Supplemental Identifiers

RxCUI
1111339
UNII
2XG66W44KF

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name olopatadine hydrochloride ophthalmic solution (source: ndc)
Generic Name olopatadine hydrochloride ophthalmic solution (source: ndc)
Application Number ANDA209619 (source: ndc)
Routes
OPHTHALMIC
source: ndc

Resolved Composition

Strengths
  • 1 mg/mL
source: ndc
Packaging
  • 1 BOTTLE, PLASTIC in 1 CARTON (11673-689-05) / 5 mL in 1 BOTTLE, PLASTIC
source: ndc

Packages (1)

11673-689-05 1 BOTTLE, PLASTIC in 1 CARTON (11673-689-05) / 5 mL in 1 BOTTLE, PLASTIC

Ingredients (1)

olopatadine hydrochloride (1 mg/mL)

Linked Drug Pages (1)

Olopatadine Hydrochloride Ophthalmic Solution ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["OPHTHALMIC"], "spl_id": "9c7c23fe-8fd3-d3b0-1410-83df55fa5db2", "openfda": {"unii": ["2XG66W44KF"], "rxcui": ["1111339"], "spl_set_id": ["02c27305-b2e8-aef3-0554-84a5db8a4695"], "manufacturer_name": ["Target Corporation"]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (11673-689-05)  / 5 mL in 1 BOTTLE, PLASTIC", "package_ndc": "11673-689-05", "marketing_start_date": "20211022"}], "brand_name": "Olopatadine Hydrochloride Ophthalmic Solution", "product_id": "11673-689_9c7c23fe-8fd3-d3b0-1410-83df55fa5db2", "dosage_form": "SOLUTION/ DROPS", "pharm_class": ["Decreased Histamine Release [PE]", "Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]", "Histamine-1 Receptor Inhibitor [EPC]", "Mast Cell Stabilizer [EPC]"], "product_ndc": "11673-689", "generic_name": "Olopatadine Hydrochloride Ophthalmic Solution", "labeler_name": "Target Corporation", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Olopatadine Hydrochloride Ophthalmic Solution", "active_ingredients": [{"name": "OLOPATADINE HYDROCHLORIDE", "strength": "1 mg/mL"}], "application_number": "ANDA209619", "marketing_category": "ANDA", "marketing_start_date": "20211022", "listing_expiration_date": "20261231"}